Interleukin 6 is a differentiation factor for human megakaryocytes in vitro
- 1 September 1990
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 20 (9) , 1927-1931
- https://doi.org/10.1002/eji.1830200909
Abstract
The response of cells of the megakaryocytic lineage to interleukin 6 (IL 6), a cytokine with multiple biological activities, was studied by adding the factor to human bone marrow (BM) cultures. IL 6 alone had no effect on megakaryocytic colony formation in methylcellulose; however, in the presence of maximally stimulating concentrations of IL 3, almost a twofold increment in colony formation was observed. Tritiated thymidine suicide studies of BM incubated for 2 h with growth factors showed that almost one‐half of megakaryocytic progenitors (CFU‐Mk) preincubated with IL3 or IL3 plus IL6 were in S phase, whereas BM incubated with IL 6 alone was similar to control (∽ 24% of CFU‐Mk in S phase). When ≧ 1 ng/ml of IL6 was added to liquid suspension cultures of BM, the size of individual megakaryocytes was significantly augmented compared with that seen in control cultures. Moreover, the DNA content of megakaryocytes grown in the presence of IL6 was increased (modal ploidy 16N) compared with cultures grown with IL3 (modal ploidy 8N). To determine if the effect of IL6 could be direct rather than mediated via accessory BM cells, the factor was added to cultures of isolated single megakaryocytes. Seventy‐one percent of cells increased in diameter in the presence of IL6, while only 27% increased in size in the absence of the factor. The data show that IL6 is a direct maturation factor for human megakaryocytes, promoting increments in size and ploidy of these cells.This publication has 32 references indexed in Scilit:
- Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.Proceedings of the National Academy of Sciences, 1989
- Recombinant interferon‐β2 (interleukin‐6) induces myeloid differentiationFEBS Letters, 1988
- Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.Proceedings of the National Academy of Sciences, 1988
- Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.Proceedings of the National Academy of Sciences, 1988
- Molecular Regulation of B Lymphocyte ResponseAnnual Review of Immunology, 1988
- Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.Proceedings of the National Academy of Sciences, 1987
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Human megakaryocytic progenitors (CFU‐M) assayed in methylcellulose: Physical characteristics and requirements for growthJournal of Cellular Physiology, 1984